MATAURO
NVO icon

MATAURO’s Novo Nordisk NVO Stock Holding History

MATAURO’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$655K Buy
17,268
+4,124
+31% +$190K 0.08% 90
2026
Q2 		$630K Buy
13,144
+3,061
+30% +$132K 0.08% 94
2026
Q1 		$371K Buy
+10,083
New +$478K 0.05% 103
2025
Q4 		– Sell
-47,076
Closed -$2.61M – 175
2025
Q3 		$2.61M Buy
47,076
+15,739
+50% +$921K 0.42% 39
2025
Q2 		$2.16M Buy
+31,337
New +$2.13M 0.41% 36

Other funds holding NVO

Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Markel Group
Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.11B AUM 22.59% 1-Year Est. Return
Nichols & Pratt Advisers
Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return
Corda Investment Management
Corda Investment Management Houston, Texas $1.52B AUM 30.53% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

MATAURO's NVO Position: Q3 2026 in Review

MATAURO increased its Novo Nordisk (NVO) stake by 31% in Q3 2026, buying an estimated $190K and bringing the position to 17,268 shares worth $655K. The position accounts for 0.08% of the portfolio, ranked #90.

MATAURO first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.61M in Q3 2025. 573 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • MATAURO held 17,268 shares of Novo Nordisk worth $655K as of Q3 2026.
  • MATAURO bought 4,124 Novo Nordisk shares in Q3 2026, an estimated $190K.
  • Novo Nordisk made up 0.08% of MATAURO's portfolio in Q3 2026, its #90 holding.
  • MATAURO first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • MATAURO's Novo Nordisk position peaked at $2.61M in Q3 2025.
  • 573 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on MATAURO's 13F filing for Q3 2026, filed 3 Nov 2026.